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BACKGROUND: Cognitive impairment, from mild forms to dementia, is an important social and health concern,
principally among older individuals. Elderly patients are usually followed by general internists, who may overlook
this condition.
OBJECTIVE: Our aim was to determine whether cognitive impairment diagnosed by specialists had been previously
detected by general internists.
SUBJECTS AND METHODS: A total of 248 elderly individuals randomly selected from a list of outpatients seen by
general internists in a public university hospital in Sa˜o Paulo, Brazil, were evaluated by a geriatrician. Patients were
then classified as having probable cognitive impairment or not, based on their performance on the Mini-Mental
State Examination and the Informant Questionnaire on Cognitive Decline in the Elderly. Cases of probable
impairment were submitted to routine laboratory investigation, brain computed tomography, and neuropsycho-
logical evaluation. The final diagnoses were established by a consensus panel comprising two neurologists and the
geriatrician who evaluated the patients using all available data. General internists’ files for all cognitively impaired
cases and for a selected sample of individuals without cognitive impairment were checked for any record of
cognitive complaints or decline.
RESULTS: Forty-three patients were classified as demented (n=21) or as cognitively impaired but not demented
(n=22). The evaluation of the general internists’ files revealed that information on cognitive complaints or decline
was recorded for seven (16.3%) of the 43 patients with dementia or cognitive impairment without dementia.
CONCLUSIONS: General internists seldom detected cognitive decline in elderly patients in Brazil. Further studies
should be conducted to elucidate the reasons for this low rate of detection.
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INTRODUCTION
Cognitive impairment, which ranges from mild cognitive
decline to dementia, represents an important social and
health concern, principally among the elderly.1 In Brazil,
most older individuals are followed by general internists
(GIs) in a range of settings, including public basic healthcare
units, university-based tertiary hospitals, and private
practices.2
Two population-based studies performed in the state of
Sa˜o Paulo, Brazil, found a prevalence of dementia from 7.1%
to 8.8% in patients aged 65 years and older.3,4 Furthermore,
the prevalence of potentially reversible dementia was found
to be 8% in a study conducted at the neurology outpatient
clinic of a university-based Brazilian tertiary hospital.5
Several studies in the medical literature have shown that
in the elderly, cognitive impairment and other neuropsy-
chiatric disorders, such as depression, are frequently
undiagnosed in primary care settings in multiple coun-
tries.6-10 Other studies have also found GI expertise on
dementia to be lacking.11,12
The aim of this study was to determine whether GIs are
effectively diagnosing cognitive impairment and dementia
in Brazil.
SUBJECTS AND METHODS
The study was conducted at two outpatient services, the
General Teaching Outpatient Service (GTOS) and the
Internal Medicine Outpatient Service (IMOS), both run by
the Internal Medicine Department of the Hospital das
Clı´nicas of the University of Sa˜o Paulo Medical School, a
public university hospital in Brazil. In the GTOS, patients
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who are referred by physicians from the Emergency Unit
are seen and treated in up to three medical consultations. In
the GTOS, interns and medical residents examine patients
and discuss all clinical cases with experienced GIs. In the
IMOS, patients are followed for longer periods because they
usually harbor more chronic conditions. Experienced GIs
and residents of the Internal Medicine Department care for
these patients.
We assumed that the prevalence of cognitive impairment
in the elderly within hospital settings is approximately 20%.
Thus, to evaluate 50 individuals with cognitive impairment,
we estimated that 250 patients should be screened. The
inclusion criteria were as follows: to have been followed at
one of the two outpatient services, aged 65 or older, and
contactable by telephone. Patients were contacted by
telephone and invited to undergo a cognitive evaluation.
To assure the randomness of the sample, a list randomizer
was used. We initially invited patients selected from a list of
1,480 elderly individuals seen by GIs during a three-month
period (November 1, 2003 to January 31, 2004). Of 296
patients contacted by telephone, 118 patients agreed to be
evaluated by the geriatrician. These evaluations were
conducted up to May 2005. To provide a shorter interval
between the evaluations by the GI and the geriatrician, a
second list of 1637 elderly patients seen by GIs from a
different three-month period (June 1 to August 31, 2005)
was used. Of the 204 contacted patients from this second
list, 130 patients were evaluated up to May 2006. Thus, the
final sample comprised 248 elderly patients who underwent
evaluation by the geriatrician. It was not possible to
compare the included subjects with the patients who
refused evaluation.
The patients’ informants were invited to accompany the
patients during the first evaluation. When this was not
possible, informants were later contacted by telephone to
gather further information on the patient’s cognitive status.
All of the participants signed a written consent form before
taking part in the study.
The assessment consisted of recording subjective memory
complaints, medical antecedents, and use of medications as
well as the application of the following tests and question-
naires: the Mini-Mental State Examination (MMSE),13,14 the
short version of the Informant Questionnaire on Cognitive
Decline in the Elderly (Short-IQCODE),15 the Brief Screening
Cognitive Battery,16-18 the Functional Activities Question-
naire (FAQ),19 the Forward and Backward Digit Span, and the
15-item Geriatric Depression Scale (GDS).20 Initially, Short-
IQCODE and MMSE scores were used to classify patients as
having probable cognitive impairment or otherwise, as
recommended by previous Brazilian studies.14,21 These two
screening instruments were chosen because they are fre-
quently used in Brazil.16 The MMSE is a brief neuropsycho-
logical screening instrument consisting of questions on
temporal and spatial orientation, immediate memory, atten-
tion/concentration, delayed recall, and language as well as a
task involving the copy of a drawing. The maximum score is
30. The short version of the IQCODE is a 16-item ques-
tionnaire, in which an informant compares the patient’s
current versus previous (ten years ago) cognitive perfor-
mance. Scores higher than three are suggestive of decline, and
the worst possible score is five. Patients with either a below-
normal score on the MMSE or an above-normal score on the
Short-IQCODE were classified as probable cases (suspected
cognitive impairment). A group of patients with normal
scores on both tests was randomly selected (non-probable
case group) to serve as the control for comparison. The
probable cases underwent neuropsychological evaluation,
including the Dementia Rating Scale,22,23 laboratory tests
(blood count, thyroid hormones, syphilis serology, liver
function, kidney function, vitamin B12, and folic acid levels),
and a brain computed tomography (CT) scan.24 Non-probable
cases were not submitted to this evaluation.
The final diagnoses were established in a consensus
meeting of two neurologists specializing in dementia and
the geriatrician who evaluated the patients using all
available data. The probable cases and the control group
were evaluated on the basis of clinical data, performances
on neuropsychological tests and questionnaires, and the
probable cases were also diagnosed using their laboratory
and CT results. Patients were classified as having demen-
tia,25 being cognitively impaired but not demented (CIND)26
or being without cognitive impairment. The GIs’ files were
checked for any record of cognitive impairment in both the
probable and non-probable cases. All GIs’ notes until the
patients’ last appointment (prior to their evaluation by the
geriatrician) were checked. Figure 1 shows the diagnosis
flowchart.
The Ethics Committee of the Hospital das Clı´nicas of the
University of Sa˜o Paulo Medical School in Brazil approved
this study.
Statistical analysis
Statistical analysis was used to compare the three groups:
‘‘dementia’’, ‘‘cognitive impairment with no dementia’’
(CIND), and ‘‘without cognitive impairment’’. Continuous
variables were compared using the non-parametric Kruskal-
Wallis test followed by a multiple comparisons test (Dunn’s
post-hoc test). Frequencies of categorical variables were
compared using the Chi-square test. Data were analyzed
using SPSS (Statistical Package for Social Sciences) version
11.5 for Windows. The accepted level of significance was set
at 0.05.
RESULTS
Of the 248 evaluated elderly patients, 52 were classified as
probable cases of cognitive impairment and 196 as without
cognitive impairment, based on the screening interview. For
the control group, 53 individuals were randomly selected
from the 196 subjects without cognitive impairment.
Although many patients were undergoing treatment for
chronic disorders at the time of the interview, in no case did
these disorders hamper the cognitive evaluation. The
median age and level of education of these subjects are
shown in Table 1. A difference in education was found
among the three groups (p= 0.02), with the dementia group
that had a lower level of education than the group of healthy
individuals.
Of the 52 probable cases, 33 were seen by GIs at the IMOS
and 19 at the GTOS unit. Eighteen individuals had scores
below the cutoff on the MMSE; 12 had above-cutoff scores
on the IQCODE; and 22 were impaired according to both
questionnaires. The mean time interval between the GI
evaluation and the geriatrician evaluation was 5.0 (¡1.7)
months.
Forty-three probable-case patients underwent neuropsy-
chological evaluation, and six subjects were not submitted
to further neuropsychological evaluation due to severe
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cognitive impairment. Two individuals refused further
evaluation after the first appointment, and one moved to
another town.
All 52 probable cases and the 53 control cases without
cognitive impairment were evaluated at the consensus
meeting. Of the 52 probable cases, 21 were given a final
diagnosis of dementia, and 22 were diagnosed with CIND,
producing a total prevalence of cognitive impairment of
17.3%. None of the cases without cognitive impairment
were diagnosed as having dementia or CIND at the
consensus meeting. Table 2 shows the nosological diagnoses
of the probable and non-probable case groups.
Information related to cognitive impairment was found in
the outpatient service medical records of seven (16.3%) of
the 43 patients diagnosed with dementia or CIND. Six of
these seven cases had moderate or severe dementia based
on MMSE and Short-IQCODE scores, while one case had
CIND (Table 3). These seven patients had been seen at either
the GTOS (4 patients) or the IMOS (3 patients). All of the
information related to cognitive impairment recorded in the
Figure 1 - Flow diagram from outpatient services to study completion. BCSB: Brief Cognitive Screening Battery. CT: Computed
Tomography. FAQ: Functional Activities Questionnaire. GDS: Geriatric Depression Scale. MMSE: Mini-Mental State Exam. Short-
IQCODE: Informant Questionnaire on Cognitive Decline in the Elderly (short version).
CLINICS 2011;66(8):1379-1384 Detection of dementia by general internists
Jacinto AF et al.
1381
outpatient service files is shown in Table 3. No record of
cognitive impairment was present in the GI files for the 53
cases without cognitive impairment.
DISCUSSION
GIs had previously identified 16.3% of the cases that were
later diagnosed with dementia (6 cases) or CIND (1 case) by
specialists. Each of these seven patients had been seen by a
different GI; four were seen at one outpatient service,
whereas three were seen in the other service, indicating that
the lack of recognition of cognitive impairment did not
come from a specific professional or outpatient service. It
should be emphasized that there was no record of cognitive
or functional decline in the files of 15 patients diagnosed
with dementia, despite the fact that this study was
conducted in a university-based tertiary hospital where
professionals are highly qualified and kept abreast of recent
scientific developments.
Two studies adopting a similar methodology (analyzing
GIs’ files after specialists had diagnosed cognitive impair-
ment in elderly patients) have also been published. Valcour
et al. reported that 65% of the dementia cases diagnosed by
geriatricians in their study had previously been identified
by GIs who had followed these patients routinely.6 Another
study using a similar methodology was conducted in
Chicago, Illinois (USA) and showed that less than 20% of
the cognitively impaired cases had been previously
recorded as such in the GIs’ files.8
In 2000, Renshaw et al. demonstrated that doctors in the
United Kingdom believed that knowledge about the
symptoms of cognitive impairment in the elderly is not
important because there is no effective treatment for these
conditions. The same study also revealed that these
professionals felt they had received insufficient training on
dementia issues in their medical graduate programs.11
In Canada and Australia, Lorentz et al. showed that GIs
felt that applying cognitive tests in their work settings (a
large number of patients and a short period to attend to
them) was not feasible because these instruments are very
complex and time consuming.7
The present study did not investigate knowledge about
dementia and its respective diagnostic tools among the GIs.
The medical literature shows GIs’ knowledge about demen-
tia to be limited, and this might explain the findings of our
study.11,12 In Brazil, Bertolucci et al. gave a questionnaire
about dementia knowledge to specialists (geriatricians,
psychiatrists, and neurologists) and GIs. The results
revealed that GIs had less knowledge about dementia than
did neurologists, psychiatrists, and geriatricians.12 Other
factors that may be causally related to the low diagnostic
rate of cognitive impairment in our study are the difficulties
that GIs face in the public healthcare system, where there is
limited time available for each appointment and where
patients often present with multiple co-morbidities. Another
factor contributing to the under-reporting of the condition
could be the low educational level of the patients and
caregivers in this study, who consequently reported few or
Table 1 - Age, education level and gender of the subjects with and without cognitive impairment.
NCI
(n = 53)
CIND
(n=22)
Dementia
(n= 21) p-value Multiple comparisons
Age,
median
(IQI)
70
(67-74)
69.5
(67-73)
72
(67-75)
0.28* Dementia =CIND=NCI
Years of Education
Median
(IQI)
4
(3-10)
4
(2-8)
2
(2-4)
0.02* Dementia =CIND{
CIND=NCI
Dementia,WCI
Gender
(Female)
37(69.8%) 20(90.9%) 18(85.7%) 0.71 Dementia =CIND=NCI
*Kruskal-Wallis test; {Dunn’s post hoc test; IQI: interquartile interval; 1Chi-Square Test; CIND: cognitive impairment with no dementia; NCI: no cognitive
impairment.
Table 2 - Nosological diagnoses of individuals in the probable case group and in a subsample of the non-probable case
group.
Diagnosis
Probable cases (%)
(n = 52)
Sample of
non-probable cases (%)
(n = 53)
Probable AD 12 (23.0) 0
AD+cerebrovascular disease 4 (7.7) 0
Vascular dementia 2 (3.8) 0
Dementia due to intracranial mass lesions 1 (1.9) 0
Parkinson’s disease dementia 1 (1.9) 0
Alcoholic dementia 1 (1.9) 0
CIND 22 (42.3) 0
Depression 0 7 (13.2)
Not cognitively impaired (only subjective memory complaint) 2 (3.8) 17 (32.0)
No subjective or objective cognitive impairment 4 (7.7) 29 (54.7)
No diagnosis (insufficient data) 3 (5.8) 0
AD: Alzheimer’s disease; CIND: cognitive impairment with no dementia.
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no complaints of cognitive impairment. A limitation of this
study might be the fact that it was conducted at one specific
location (University Hospital in Sa˜o Paulo), so these
findings cannot be generalized to all of Brazilian society.
Problems associated with an aging population were faced
by economically developed countries almost one century ago.
Brazil is now having to deal with the rapid aging of its
population and should begin developing strategies in the
near future to avoid serious repercussions. In Brazil, despite
the efforts of public officials, there has been little reform of the
public healthcare system to cater to an aging population, and
the elderly encounter difficulties when seeking public
healthcare services. Access to services equipped to receive
older patients remains very limited. Basic healthcare units
and even some large tertiary hospitals (university-associated
or otherwise) are inadequately prepared for the growing
demands placed on them by the elderly population.27
Advanced medical and scientific resources allow the early
detection of diseases; cancer, diabetes, arterial hypertension,
osteoporosis, and dyslipidemia are examples of diseases
commonly screened for in public health programs on a
preventive basis. However, the different types of dementia
are often excluded from such programs despite their high
prevalence.28,29
Dementia is the largest contributor to disability in elderly
people in countries with low and middle incomes,30 and the
societal costs of dementia have been increasing in recent
years.31 Early diagnosis of cognitive impairment is impor-
tant for several reasons. Ruling out potentially reversible
conditions is the most relevant of these reasons, but
providing more detailed instructions on how to take
medications is another significant reason. The safety of the
patient and of others may be safeguarded by preventing car
accidents and disease complications arising from patients’
inability to take care of themselves.32-34 For the patient and
his/her family, a diagnosis of cognitive impairment has an
impact on their plans for the future, including financial and
legal matters.35,36
Mild cognitive decline that does not significantly affect
patients’ daily living activities may be more frequently
overlooked by GIs. In this study, only one case classified as
CIND contained a report of cognitive impairment in the GI
file. Considering that patients with CIND may have higher
rates of progression to dementia than non-impaired
subjects, this diagnosis may be relevant for the patient.37
A note of caution should be made regarding the 17.3%
prevalence of cognitive impairment found in this study. In
spite of the random selection of cases selected for evaluation,
many of them could not participate, and only a small sample
was interviewed. It is possible that those who came for the
interview had greater concerns about their cognitive functions.
Further studies should be conducted to elucidate the
reasons underlying the low detection of cognitive impair-
ment by GIs and to investigate the advantages and pitfalls of
early detection of dementia.
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